It’s a scenario many primary care physicians are increasingly encountering: a patient, often young, walks in with a letter. This letter, sometimes prompted by a viral TikTok video or a quick online search, recommends a specific diagnosis and even a particular medication, like lisdexamfetamine (Vyvanse). The patient, eager for answers and relief, wants you to simply write the prescription.
This situation, as highlighted by the Therapeutics Initiative, points to a growing concern about the overdiagnosis of adult ADHD and a subsequent prescribing epidemic for stimulant medications. It’s easy to see why patients might feel a letter, especially one based on a self-report scale, is a straightforward path to treatment. After all, who wouldn't want a quick fix for feeling easily distracted or overwhelmed?
But here's the thing: diagnosing ADHD, especially in adults, is far more complex than a single score on a questionnaire. It’s not like checking off boxes on a form. A reliable diagnosis requires a deep dive into a person's history – not just recent struggles, but documented symptoms that began in childhood. This means understanding family dynamics, developmental milestones, and observing how these patterns have played out over time. A rating scale, while a useful tool, simply can't replace that comprehensive clinical assessment.
And then there's the medication itself. While industry-funded studies often show short-term benefits on subjective symptom scales, we know surprisingly little about the long-term functional outcomes. Does it truly improve social success or employment stability? What about overall health? The evidence suggests that while stimulants might temporarily mask symptoms, they don't necessarily enhance or normalize the ability to learn or apply knowledge in everyday life. Plus, many adults experience adverse effects, and there are real concerns about tolerance, dependence, and withdrawal.
It’s also worth noting that some medications, like lisdexamfetamine (Vyvanse), come with a significantly higher price tag, yet there's no proven advantage over other, less expensive stimulants. This adds another layer of complexity when considering treatment options.
So, what's a doctor to do when faced with that letter and an expectant patient? It’s about having an open, honest conversation. It's about explaining that while their feelings of distraction are valid and deserve attention, a diagnosis needs careful consideration. It’s about gently guiding them through the process, emphasizing that a thorough assessment is crucial for finding the right path forward, one that prioritizes their long-term well-being over a quick prescription. The goal isn't just to treat a label, but to truly understand and support the individual.
